{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:12:52Z","timestamp":1747195972990,"version":"3.40.5"},"reference-count":93,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Research and Innovation Fund"},{"name":"Postdoctoral Fellowship Award from Mahidol University"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p><jats:italic>Plasmodium vivax<\/jats:italic> malaria causes significant public health problems in endemic regions. Considering the rapid spread of drug-resistant parasite strains and the development of hypnozoites in the liver with potential for relapse, development of a safe and effective vaccine for preventing, controlling, and eliminating the infection is critical. Immunity to malaria is mediated by antibodies that inhibit sporozoite or merozoite invasion into host cells and protect against clinical disease. Epidemiologic data from malaria endemic regions show the presence of naturally acquired antibodies to <jats:italic>P<\/jats:italic>. <jats:italic>vivax<\/jats:italic> antigens during and following infection. But data on the persistence of these antibodies, development of <jats:italic>P<\/jats:italic>. <jats:italic>vivax<\/jats:italic>-specific memory B cells (MBCs), and their relation to reduction of malaria severity and risk is limited. This review provides an overview of the acquisition and persistence of naturally acquired humoral immunity to <jats:italic>P<\/jats:italic>. <jats:italic>vivax<\/jats:italic> infection. Also, we summarize and discuss current progress in assessment of immune responses to candidate vaccine antigens in <jats:italic>P<\/jats:italic>. <jats:italic>vivax<\/jats:italic> patients from different transmission settings. Longitudinal studies of MBC and antibody responses to these antigens will open new avenues for developing vaccines against malaria infection and its transmission.<\/jats:p>","DOI":"10.1371\/journal.pntd.0012600","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T17:23:21Z","timestamp":1729790601000},"page":"e0012600","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and longevity of naturally acquired antibody and memory B cell responses against Plasmodium vivax infection"],"prefix":"10.1371","volume":"18","author":[{"given":"Pongsakorn","family":"Thawornpan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyawan","family":"Kochayoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfa Zahra","family":"Salsabila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-4494","authenticated-orcid":true,"given":"Patchanee","family":"Chootong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"pntd.0012600.ref001","unstructured":"Organization WH. World Malaria Report 2023. World Health Organization: 2023."},{"issue":"1","key":"pntd.0012600.ref002","doi-asserted-by":"crossref","first-page":"e1003890","DOI":"10.1371\/journal.pmed.1003890","article-title":"Clinical impact of vivax malaria: a collection review","volume":"19","author":"AP Phyo","year":"2022","journal-title":"PLoS Med"},{"key":"pntd.0012600.ref003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpddr.2021.04.002","article-title":"The molecular basis of antimalarial drug resistance in Plasmodium vivax","volume":"16","author":"LE Buyon","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"7","key":"pntd.0012600.ref004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/cid\/ciab610","article-title":"Relapse of Plasmodium vivax and Plasmodium ovale malaria with and without primaquine treatment in a nonendemic area","volume":"74","author":"A W\u00e5ngdahl","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0012600.ref005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix): an overview","volume":"16","author":"MB Laurens","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"pntd.0012600.ref006","article-title":"Plasmodium vivax Duffy Binding Protein-based vaccine: a distant dream","volume":"12","author":"S Kar","year":"2022","journal-title":"Frontiers in Cellular and Infection. Microbiology"},{"key":"pntd.0012600.ref007","doi-asserted-by":"crossref","first-page":"102411","DOI":"10.1016\/j.parint.2021.102411","article-title":"Plasmodium vivax pre-erythrocytic vaccines","volume":"84","author":"A. Reyes-Sandoval","year":"2021","journal-title":"Parasitol Int"},{"issue":"7","key":"pntd.0012600.ref008","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Y Wu","year":"2008","journal-title":"PLoS ONE"},{"issue":"9","key":"pntd.0012600.ref009","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ng.2373","article-title":"The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum","volume":"44","author":"DE Neafsey","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"pntd.0012600.ref010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20101488","article-title":"The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host","volume":"208","author":"A Coppi","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"pntd.0012600.ref011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.actatropica.2004.02.011","article-title":"HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria","volume":"92","author":"J Oliveira-Ferreira","year":"2004","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0012600.ref012","doi-asserted-by":"crossref","first-page":"e0004423","DOI":"10.1371\/journal.pntd.0004423","article-title":"Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy","volume":"10","author":"JW Bennett","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"pntd.0012600.ref013","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijpara.2004.10.009","article-title":"Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein","volume":"34","author":"S Herrera","year":"2004","journal-title":"International Journal for Parasitology"},{"issue":"2","key":"pntd.0012600.ref014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2011.09-0516","article-title":"Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with Montanide ISA 720 or Montanide ISA 51","volume":"84","author":"S Herrera","year":"2011","journal-title":"Am Soc Trop Med Hygiene"},{"key":"pntd.0012600.ref015","doi-asserted-by":"crossref","first-page":"1372584","DOI":"10.3389\/fimmu.2024.1372584","article-title":"A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study","volume":"15","author":"Y Yamamoto","year":"2024","journal-title":"Front Immunol"},{"issue":"704","key":"pntd.0012600.ref016","article-title":"Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection","volume":"15","author":"MM Hou","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"pntd.0012600.ref017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41541-018-0083-3","article-title":"Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial","volume":"3","author":"K Singh","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"24","key":"pntd.0012600.ref018","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0012600.ref019","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41598-024-51820-2","article-title":"Naturally acquired antibodies against Plasmodium vivax pre-erythrocytic stage vaccine antigens inhibit sporozoite invasion of human hepatocytes in vitro","volume":"14","author":"FB Ntumngia","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"pntd.0012600.ref020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/tmi.13083","article-title":"Naturally acquired IgG antibodies to thrombospondin-related anonymous protein of Plasmodium vivax (PvTRAP) in Thailand predominantly elicit immunological cross-reactivity","volume":"23","author":"R Kosuwin","year":"2018","journal-title":"Trop Med Int Health"},{"issue":"2","key":"pntd.0012600.ref021","doi-asserted-by":"crossref","first-page":"e0005344","DOI":"10.1371\/journal.pntd.0005344","article-title":"Plasmodium vivax cell traversal protein for ookinetes and sporozoites (PvCelTOS) gene sequence and potential epitopes are highly conserved among isolates from different regions of Brazilian Amazon","volume":"11","author":"L Bitencourt Chaves","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0012600.ref022","doi-asserted-by":"crossref","first-page":"e0011598","DOI":"10.1371\/journal.pntd.0011598","article-title":"Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates","volume":"17","author":"J Nicholas","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0012600.ref023","doi-asserted-by":"crossref","first-page":"e0011907","DOI":"10.1371\/journal.pntd.0011907","article-title":"Longitudinal analysis of antibody responses to Plasmodium vivax sporozoite antigens following natural infection","volume":"18","author":"P Thawornpan","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0012600.ref024","doi-asserted-by":"crossref","first-page":"e28126","DOI":"10.1371\/journal.pone.0028126","article-title":"Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax","volume":"6","author":"F Yildiz Zeyrek","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"pntd.0012600.ref025","doi-asserted-by":"crossref","first-page":"14020","DOI":"10.1038\/s41598-020-70893-3","article-title":"Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon","volume":"10","author":"IF Soares","year":"2020","journal-title":"Sci Rep"},{"key":"pntd.0012600.ref026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.actatropica.2017.05.026","article-title":"Naturally acquired immune responses to thrombospondin-related adhesion protein (TRAP) of Plasmodium vivax in patients from areas of unstable malaria transmission","volume":"173","author":"S Nazeri","year":"2017","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0012600.ref027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/CVI.00501-15","article-title":"Acquisition and longevity of antibodies to Plasmodium vivax preerythrocytic antigens in western Thailand","volume":"23","author":"J Longley Rhea","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"pntd.0012600.ref028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12936-017-1837-5","article-title":"Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection","volume":"16","author":"Y Cheng","year":"2017","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref029","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12936-017-2000-z","article-title":"Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses","volume":"16","author":"HMK Min","year":"2017","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref030","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/s41598-021-82928-4","article-title":"Immunoglobulin G responses to variant forms of Plasmodium vivax merozoite surface protein 9 upon natural infection in Thailand","volume":"11","author":"S Songsaigath","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"pntd.0012600.ref031","doi-asserted-by":"crossref","first-page":"e0151900","DOI":"10.1371\/journal.pone.0151900","article-title":"Naturally acquired antibody responses to Plasmodium vivax and Plasmodium falciparum merozoite surface protein 1 (MSP1) C-terminal 19 kda domains in an area of unstable malaria transmission in Southeast Asia","volume":"11","author":"Q Wang","year":"2016","journal-title":"PLoS ONE"},{"key":"pntd.0012600.ref032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2011.10-0044","article-title":"Evaluation of the naturally acquired antibody immune response to the Pv200l N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon region of Brazil","volume":"84","author":"L Storti-Melo","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0012600.ref033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-015-0681-8","article-title":"Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen","volume":"14","author":"S Changrob","year":"2015","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref034","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1038\/s41598-024-59153-w","article-title":"Anti-Plasmodium vivax merozoite surface protein 3 \u03d2 (PvMSP3 \u03d2) antibodies upon natural infection","volume":"14","author":"N Kuamsab","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"pntd.0012600.ref035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molbiopara.2004.09.012","article-title":"Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103","volume":"139","author":"JA Pearce","year":"2005","journal-title":"Mol Biochem Parasitol"},{"issue":"11","key":"pntd.0012600.ref036","doi-asserted-by":"crossref","first-page":"e2498","DOI":"10.1371\/journal.pntd.0002498","article-title":"Naturally acquired immune responses to P. vivax merozoite surface protein 3\u03b1 and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children","volume":"7","author":"DI Stanisic","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0012600.ref037","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1039\/C5MB00330J","article-title":"An immunomics approach for the analysis of natural antibody responses to Plasmodium vivax infection","volume":"11","author":"J-H Chen","year":"2015","journal-title":"Mol Biosyst"},{"issue":"38","key":"pntd.0012600.ref038","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1016\/j.vaccine.2010.07.017","article-title":"A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice","volume":"28","author":"F Gentil","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0012600.ref039","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12936-019-3009-2","article-title":"The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission","volume":"18","author":"P Kochayoo","year":"2019","journal-title":"Malar J"},{"issue":"8","key":"pntd.0012600.ref040","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nsmb.2088","article-title":"Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC","volume":"18","author":"JD Batchelor","year":"2011","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"pntd.0012600.ref041","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/IAI.01036-09","article-title":"Mapping epitopes of the Plasmodium vivax Duffy Binding Protein with naturally acquired inhibitory antibodies","volume":"78","author":"P Chootong","year":"2010","journal-title":"Infect Immun"},{"issue":"5","key":"pntd.0012600.ref042","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/IAI.71.5.2508-2515.2003","article-title":"Epitope-specific humoral immunity to Plasmodium vivax Duffy Binding Protein","volume":"71","author":"J Xainli","year":"2003","journal-title":"Infect Immun"},{"issue":"12","key":"pntd.0012600.ref043","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1371\/journal.pmed.0040337","article-title":"Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy Binding Protein","volume":"4","author":"BT Grimberg","year":"2007","journal-title":"PLoS Med"},{"issue":"6","key":"pntd.0012600.ref044","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.parint.2014.07.014","article-title":"The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand","volume":"63","author":"P Chootong","year":"2014","journal-title":"Parasitol Int"},{"issue":"10","key":"pntd.0012600.ref045","doi-asserted-by":"crossref","first-page":"e0276335","DOI":"10.1371\/journal.pone.0276335","article-title":"Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection","volume":"17","author":"P Thawornpan","year":"2022","journal-title":"PLoS ONE"},{"issue":"5","key":"pntd.0012600.ref046","doi-asserted-by":"crossref","first-page":"e0154577","DOI":"10.1371\/journal.pone.0154577","article-title":"Strain-transcending inhibitory antibodies against homologous and heterologous strains of Duffy Binding Protein region II","volume":"11","author":"S Wongkidakarn","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"pntd.0012600.ref047","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1038\/s41598-023-34903-4","article-title":"Characterization of Duffy Binding Protein II-specific CD4+T cell responses in Plasmodium vivax patients","volume":"13","author":"P Thawornpan","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"pntd.0012600.ref048","doi-asserted-by":"crossref","first-page":"e21289","DOI":"10.1371\/journal.pone.0021289","article-title":"Identification of a highly antigenic linear B cell epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)","volume":"6","author":"LL Bueno","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"pntd.0012600.ref049","doi-asserted-by":"crossref","first-page":"e12705","DOI":"10.1111\/pim.12705","article-title":"Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria","volume":"42","author":"RR Soares","year":"2020","journal-title":"Parasite Immunol"},{"issue":"12","key":"pntd.0012600.ref050","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.micinf.2008.07.023","article-title":"Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection","volume":"10","author":"BC M\u00fafalo","year":"2008","journal-title":"Microbes Infect"},{"issue":"1","key":"pntd.0012600.ref051","first-page":"e13110","article-title":"Plasmodium vivax reticulocyte binding proteins for invasion into reticulocytes","volume":"22","author":"L-J Chan","year":"2020","journal-title":"Cell Microbiol"},{"issue":"7","key":"pntd.0012600.ref052","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jiy273","article-title":"Identification and immunological characterization of the ligand domain of Plasmodium vivax Reticulocyte Binding Protein 1a","volume":"218","author":"FB Ntumngia","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0012600.ref053","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12936-017-1826-8","article-title":"Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand","volume":"16","author":"RJ Longley","year":"2017","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref054","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12936-017-1967-9","article-title":"Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure","volume":"16","author":"S Changrob","year":"2017","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref055","doi-asserted-by":"crossref","first-page":"35581","DOI":"10.1038\/srep35581","article-title":"Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status","volume":"6","author":"Y Cheng","year":"2016","journal-title":"Sci Rep"},{"key":"pntd.0012600.ref056","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1076150","article-title":"Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria","volume":"13","author":"R Mazhari","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"pntd.0012600.ref057","doi-asserted-by":"crossref","unstructured":"Bittencourt NC, Leite JA, Silva ABIE, Pimenta TS, Silva-Filho JL, Cassiano GC, et al. Genetic sequence characterization and naturally acquired immune response to Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2). Malar J. 2018;17(1):401. doi: 10.1186\/s12936-018-2543-7. PMID: 30382855.","DOI":"10.1186\/s12936-018-2543-7"},{"issue":"2","key":"pntd.0012600.ref058","doi-asserted-by":"crossref","first-page":"e0148723","DOI":"10.1371\/journal.pone.0148723","article-title":"Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen","volume":"11","author":"S Changrob","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"pntd.0012600.ref059","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/IAI.68.12.6618-6623.2000","article-title":"Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes","volume":"68","author":"H Hisaeda","year":"2000","journal-title":"Infect Immun"},{"key":"pntd.0012600.ref060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1106369","article-title":"Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of Plasmodium vivax gametocytes to Anopheles arabiensis mosquitoes","volume":"12","author":"SK Tebeje","year":"2023","journal-title":"Front Cell Inf Microbiol"},{"issue":"1","key":"pntd.0012600.ref061","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2875-6-107","article-title":"Transmission-blocking activity induced by malaria vaccine candidates Pfs25\/Pvs25 is a direct and predictable function of antibody titer","volume":"6","author":"K Miura","year":"2007","journal-title":"Malar J"},{"key":"pntd.0012600.ref062","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3389\/fimmu.2019.02295","article-title":"Naturally acquired antibody response to malaria transmission blocking vaccine candidate Pvs230 domain 1","volume":"10","author":"BCN Tentokam","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"pntd.0012600.ref063","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2249.2009.03931.x","article-title":"Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection","volume":"156","author":"IP Ceravolo","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"pntd.0012600.ref064","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41577-019-0209-5","article-title":"Antibodies against Plasmodium falciparum malaria at the molecular level","volume":"19","author":"J-P Julien","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"pntd.0012600.ref065","doi-asserted-by":"crossref","first-page":"e1000770","DOI":"10.1371\/journal.ppat.1000770","article-title":"Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax","volume":"6","author":"J Wipasa","year":"2010","journal-title":"PLoS Pathog"},{"key":"pntd.0012600.ref066","doi-asserted-by":"crossref","first-page":"e35832","DOI":"10.7554\/eLife.35832","article-title":"Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure","volume":"7","author":"I Rodriguez-Barraquer","year":"2018","journal-title":"Elife"},{"issue":"1","key":"pntd.0012600.ref067","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12936-018-2622-9","article-title":"Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka","volume":"17","author":"RL Dewasurendra","year":"2018","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref068","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12916-022-02281-9","article-title":"Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand","volume":"20","author":"ZS-J Liu","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"pntd.0012600.ref069","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1038\/s41598-018-26677-x","article-title":"Persistence of long-lived memory B cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax","volume":"8","author":"S Changrob","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"pntd.0012600.ref070","doi-asserted-by":"crossref","first-page":"e0010493","DOI":"10.1371\/journal.pntd.0010493","article-title":"Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure","volume":"16","author":"BAS Lima","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0012600.ref071","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12936-019-2821-z","article-title":"The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection","volume":"18","author":"P Kochayoo","year":"2019","journal-title":"Malar J"},{"issue":"1","key":"pntd.0012600.ref072","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12936-021-04015-3","article-title":"The presence of circulating antibody secreting cells and long-lived memory B cell responses to reticulocyte binding protein 1a in Plasmodium vivax patients","volume":"20","author":"P Kochayoo","year":"2021","journal-title":"Malar J"},{"issue":"11","key":"pntd.0012600.ref073","doi-asserted-by":"crossref","first-page":"e0010773","DOI":"10.1371\/journal.pntd.0010773","article-title":"Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon","volume":"16","author":"T Tashi","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0012600.ref074","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CDLI.8.1.14-20.2001","article-title":"Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea","volume":"8","author":"JW Park","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"pntd.0012600.ref075","doi-asserted-by":"crossref","first-page":"105537","DOI":"10.1016\/j.actatropica.2020.105537","article-title":"Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil","volume":"209","author":"EMF Costa","year":"2020","journal-title":"Acta Trop"},{"issue":"1","key":"pntd.0012600.ref076","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12936-024-04978-z","article-title":"Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin","volume":"23","author":"JA Ventocilla","year":"2024","journal-title":"Malar J"},{"issue":"5","key":"pntd.0012600.ref077","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00436-003-1009-0","article-title":"Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax","volume":"92","author":"KJ Lim","year":"2004","journal-title":"Parasitol Res"},{"key":"pntd.0012600.ref078","doi-asserted-by":"crossref","first-page":"950909","DOI":"10.3389\/fcimb.2022.950909","article-title":"Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity","volume":"12","author":"Y Tayipto","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"pntd.0012600.ref079","doi-asserted-by":"crossref","DOI":"10.3390\/antib13030069","article-title":"Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study","volume":"13","author":"CM Rodolphi","year":"2024","journal-title":"Antibodies"},{"issue":"1","key":"pntd.0012600.ref080","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1038\/s41598-022-08976-6","article-title":"Interferon-\u03b3 signal drives differentiation of T-bethi atypical memory B cells into plasma cells following Plasmodium vivax infection","volume":"12","author":"P Kochayoo","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"pntd.0012600.ref081","doi-asserted-by":"crossref","first-page":"e1000912","DOI":"10.1371\/journal.ppat.1000912","article-title":"The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections","volume":"6","author":"GE Weiss","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"pntd.0012600.ref082","doi-asserted-by":"crossref","first-page":"e1006576","DOI":"10.1371\/journal.ppat.1006576","article-title":"Malaria-induced interferon-\u03b3 drives the expansion of Tbethi atypical memory B cells","volume":"13","author":"N Obeng-Adjei","year":"2017","journal-title":"PLoS Pathog"},{"key":"pntd.0012600.ref083","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00852","article-title":"The differentiation in vitro of human tonsil B cells with the phenotypic and functional characteristics of T-bet+ atypical memory B cells in malaria","volume":"10","author":"AA Ambegaonkar","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0012600.ref084","doi-asserted-by":"crossref","first-page":"e07218","DOI":"10.7554\/eLife.07218","article-title":"Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function","volume":"4","author":"S Portugal","year":"2015","journal-title":"Elife"},{"issue":"6","key":"pntd.0012600.ref085","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.4049\/jimmunol.1401037","article-title":"Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels","volume":"193","author":"P Requena","year":"2014","journal-title":"J Immunol"},{"issue":"9","key":"pntd.0012600.ref086","doi-asserted-by":"crossref","first-page":"e12662","DOI":"10.1111\/pim.12662","article-title":"Apical membrane protein 1-specific antibody profile and temporal changes in peripheral blood B-cell populations in Plasmodium vivax malaria","volume":"41","author":"RR Soares","year":"2019","journal-title":"Parasite Immunol"},{"issue":"7","key":"pntd.0012600.ref087","doi-asserted-by":"crossref","first-page":"e1006484","DOI":"10.1371\/journal.ppat.1006484","article-title":"T follicular helper cells regulate the activation of B lymphocytes and antibody production during Plasmodium vivax infection","volume":"13","author":"MM Figueiredo","year":"2017","journal-title":"PLoS Pathog"},{"issue":"10","key":"pntd.0012600.ref088","doi-asserted-by":"crossref","first-page":"e12580","DOI":"10.1111\/pim.12580","article-title":"Vivax infection alters peripheral B-cell profile and induces persistent serum IgM","volume":"40","author":"M Patgaonkar","year":"2018","journal-title":"Parasite Immunol"},{"issue":"2","key":"pntd.0012600.ref089","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20121970","article-title":"Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies","volume":"210","author":"MF Muellenbeck","year":"2013","journal-title":"J Exp Med"},{"issue":"3","key":"pntd.0012600.ref090","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"GE Weiss","year":"2009","journal-title":"J Immunol"},{"key":"pntd.0012600.ref091","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.coi.2022.102227","article-title":"Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces","volume":"77","author":"AA Ambegaonkar","year":"2022","journal-title":"Curr Opin Immunol"},{"issue":"22","key":"pntd.0012600.ref092","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg8384","article-title":"Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity","volume":"7","author":"P Holla","year":"2021","journal-title":"Sci Adv"},{"issue":"71","key":"pntd.0012600.ref093","article-title":"Atypical B cells up-regulate costimulatory molecules during malaria and secrete antibodies with T follicular helper cell support","volume":"7","author":"CS Hopp","year":"2022","journal-title":"Sci Immunol"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T17:23:49Z","timestamp":1729790629000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012600"}},"subtitle":[],"editor":[{"given":"Maria Fantinatti","family":"Fernandes da Silva","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":93,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012600","relation":{},"ISSN":["1935-2735"],"issn-type":[{"type":"electronic","value":"1935-2735"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}